Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
66.57 USD | -0.54% | +0.15% | +6.97% |
Apr. 30 | Earnings Flash (AXNX) AXONICS Reports Q1 Revenue $91.4M | MT |
Apr. 04 | Boston Scientific, Axonics Receive FTC Second Request on Merger Deal | MT |
Financials (USD)
Sales 2024 * | 448M | Sales 2025 * | 534M | Capitalization | 3.4B |
---|---|---|---|---|---|
Net income 2024 * | 25M | Net income 2025 * | 37M | EV / Sales 2024 * | 6.77 x |
Net cash position 2024 * | 360M | Net cash position 2025 * | 404M | EV / Sales 2025 * | 5.6 x |
P/E ratio 2024 * |
132
x | P/E ratio 2025 * |
84.8
x | Employees | 797 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.9% |
Latest transcript on Axonics, Inc.
1 day | -0.54% | ||
1 week | +0.15% | ||
1 month | -3.48% | ||
3 months | -1.93% | ||
6 months | +29.99% | ||
Current year | +6.97% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 51 | 12-12-31 | |
Raymond Cohen
FOU | Founder | 65 | 13-09-30 |
Kari Keese
DFI | Director of Finance/CFO | 39 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Carrel
CHM | Chairman | 53 | 19-02-26 |
Nancy Snyderman
BRD | Director/Board Member | 72 | 19-04-07 |
Raymond Cohen
FOU | Founder | 65 | 13-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.98% | 11 M€ | -6.03% | - | |
0.09% | 509 M€ | -.--% | ||
0.05% | 773 M€ | -.--% | - | |
0.04% | 237 M€ | +1.29% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 66.57 | -0.54% | 645,846 |
24-04-29 | 66.93 | +0.36% | 656,211 |
24-04-26 | 66.69 | +0.23% | 318,433 |
24-04-25 | 66.54 | -0.15% | 484,280 |
24-04-24 | 66.64 | +0.26% | 396,114 |
Delayed Quote Nasdaq, April 30, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.97% | 3.4B | |
+12.37% | 128B | |
-5.97% | 10.69B | |
+2.17% | 8.93B | |
+18.79% | 7.32B | |
+20.77% | 4.82B | |
-1.41% | 3.03B | |
-5.07% | 2.23B | |
-4.22% | 2.13B | |
-20.87% | 1.84B |
- Stock Market
- Equities
- AXNX Stock